Delivery Order SPE2DB20D3101-SPE2DB24FRVA7

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,159.44, is for the delivery of Lantus 100 unit/mL vials. This is a firm fixed-price delivery order contract with an ultimate completion date of August 24, 2021. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.77 delivery order contract is for the supply of Lantus 100 unit/ml vial (10 ml), a specialty medication used for the treatment of diabetes. The contract has an ultimate completion date of May 31, 2023 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus 100 unit/mL vial 10 mL. The $1,352.48 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,709.98 firm-fixed-price contract is for the provision of Lantus 100 Unit/ML Vial 10ML, a prescription medication. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, valued at $1,153.17, is for the delivery of Lantus 100 unit/ml vial (10ml) and has a period of performance through May 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,109.16 Firm Fixed Price Delivery Order contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription medication used to treat diabetes. The contract has an ultimate completion date of January 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,695.70, is for the delivery of Lantus 100 unit/ml vial 10ml, a specialty medication used for diabetes management. This is a firm fixed-price delivery order contract with a completion date of September 20, 2023. The contract is not designated with a set-aside requirement, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,063.88, is for the delivery of Lantus 100 unit/mL vial, a medication used to treat diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,187.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription insulin medication. The contract has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award is for the delivery of Lantus 100 Unit/mL vials to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $1,187.40 and a period of performance through March 11, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRVA7
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is a Delivery Order valued at $1,008.09 for the supply of Lantus 100 unit/mL vial (10 mL). The contract has an ultimate completion date of September 17, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 10:51 AM